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Abstract 
 Cyclisation of the precursor 6 under standard radical conditions yields the tetracyclic structure 7 
which represents the core of a number of indole alkaloids along with the novel tetracycle 13. 
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Introduction 
 
The Strychnos and Aspidosperma alkaloids are structurally complex molecules that possess a 
range of biological activity and present a challenge to synthetic organic chemists.1 As part of our 
ongoing interest in these classes of alkaloids,2 we are particularly concerned with a synthesis of 
the core tetracyclic sub-structure 1, which forms the basis of these molecules as exemplified by 
strychnine 2 and aspidospermidine 3 (Figure 1). 
 
 
 
Figure 1 
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 In our previous studies, we had shown that tandem radical cyclisation of the precursor 4 
gave the tetracyclic structure 5 as a mixture of 4 diastereoisomers (Scheme 1).3 
 
 
 
Scheme 1 
 
 Whilst this route provided the core tetracyclic structure 5, it possesses limited functionality 
with which to undertake a synthesis of either the Strychnos or Aspidosperma alkaloids. We 
therefore embarked on a synthesis of a cyclisation precursor which, after cyclisation, would 
enable us to access suitable intermediates for the synthesis of these two classes of alkaloids.  The 
proposed cyclisation precursor 6 is shown below. It possesses a terminal C/C triple bond, which 
on cyclisation under our standard conditions should provide an exocyclic double bond on the 
tetracyclic product 7 (Scheme 2). This would allow further elaboration of such molecules 
towards natural products such as strychnine and aspidospermidine. 
 
 
 
Scheme 2 
 
 
Results and Discussion 
 
The required cyclisation precursor was synthesized following our previous approach from the 
sulfonamide 8 which utilized the work of Bowman and Fukuyama for the synthesis of the 
secondary amine.4,5 Reaction of 8 with 4-pentynol under Mitsunobu conditions gave the tertiary 
sulfonamide 9 in 96% yield (Scheme 3). Deprotection of the tertiary sulfonamide 9 using 
potassium carbonate and thiophenol gave the secondary amine 10 in 75% yield.5 Reaction of this 
with the acid chloride 11 following our previous work on oxindoles,6 gave the cyclisation 
precursor 6 in 86% yield as a 1:1.3 mixture of amide rotamers (Scheme 3). 
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Scheme 3. Reagents and Conditions: (i) PPh3, DEAD, THF, 0 °C, 96%; (ii) K2CO3, MeCN, 
PhSH, 75%; (iii) iPr2NEt, CH2Cl2, 0 °C, 86%. 
 
 Following the successful cyclisation of the N-pentenyl precursor 4 in our previous 
example,3 we decided to use the same conditions for cyclisation of the N-pentynyl precursor 6.  
Treatment of a solution of the tertiary amide 6 in t-butyl-m-xylene under reflux with syringe 
pump addition of a solution of tri-n-butyltin hydride and AIBN in t-butyl-m-xylene resulted in 
the formation of three isolable products.  High-resolution mass spectrometry confirmed the same 
molecular formula for all three compounds, C24H23N3O.  The least polar compound was 
identified as the reduced product 12 owing to the presence of 9 aromatic protons, the terminal 
acetylene proton and an equal mixture of amide rotamers in the 1H NMR spectrum.  It was 
isolated in 45% yield.  From the 13C NMR spectrum, the second product isolated in 16% yield 
clearly possessed an exocyclic double bond (resonance at δ 119.4) along with the distinctive 
spirocyclic center (δ 53.8), indicating that the precursor 6 had undergone the desired 
translocation-cyclisation-cyclisation sequence onto the exocyclic triple bond. This along with the 
other observable data such as two distinct AB quartets in the 1H NMR clearly indicated that we 
had indeed synthesized the tetracyclic structure 7. The relative stereochemistry of this 
diastereoisomer cannot easily be determined owing to the three contiguous quaternary centers 
but it appears to be one single diastereoisomer. 
 
 
Scheme 4 
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 The nature of the third isolable product presented a challenge, as it clearly possessed three 
AB quartets from the 1H NMR spectrum. The exocyclic double bond was also present indicating 
that the final cyclisation step had taken place. From the 13C NMR spectrum there were 5 CH2 
signals excluding the exocyclic methylene group. Eight quaternary carbons were also observed 
in the 13C NMR spectrum with no evidence for the expected N-methyl group in either the 1H or 
13C NMR spectrum.  On the basis of the evidence, we have assigned the tetracyclic structure 13 
to this compound, which was isolated in 15% yield.  The formation of this unexpected product is 
believed to have occurred by an additional 1,5-hydrogen atom abstraction by the vinylic radical 
17 from the neighbouring N-methyl group of the indole (Scheme 5).  The resultant primary 
radical 18 then undergoes a neophyl-type rearrangement by addition to the benzene ring to give 
cyclohexadienyl radical 19.  Ring-opening of 19 to regenerate the aromatic ring gives an aminyl 
radical which is reduced by tri-n-butyltin hydride to give the final compound 13. 
 
 
 
Scheme 5 
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 This unexpected product 13 possesses a novel ring structure which has arisen by a formal 
ring expansion of an indole to a tetrahydroisoquinoline. The formation of this product is 
surprising. 1,5-Hydrogen atom abstraction by a vinylic radical is well precedented7-9 as is the 
neophyl rearrangement involving an aromatic ring with concomitant ring expansion.10,11  
However, the sequential occurrence of these two reactions as part of a tandem process is 
unprecedented. 
 In summary, cyclisation of the N-pentynyl precursor 6 results in the formation of the 
expected cyclised product 7, carrying suitable functionality for conversion into natural indole 
alkaloids.  In addition, the novel tetracycle 13 has also been isolated.  We suggest that this arises 
through a combination of hydrogen atom abstraction and radical rearrangement. 
 
 
Experimental Section 
 
General Procedures. 1H NMR and 13C NMR were recorded on a Bruker AM300 spectrometer 
operating at 300 MHz for proton and 75 MHz for carbon. Infrared spectra were recorded on a 
Perkin Elmer 1605 FT-IR spectrophotometer using NaCl plates. High resolution mass spectra 
were carried out at King’s College, London University or at Kingston University.  Mass spectra 
carried out at King’s College using either a Kratos MS89MS with Kratos DS90 software or a 
Jeol AX505W with Jeol complement data system.  Samples were ionised electronically (EI), 
with an accelerating voltage of ≈6kV or by low resolution fast atom bombardment (FAB) in a 
thioglycerol matrix.  High resolution fast atom bombardment was carried out at the ULIRS mass 
spectrometry facility at the School of Pharmacy, University of London.  Mass spectra carried out 
at Kingston University were recorded using a Micromass LCT time of flight mass spectrometer 
equipped with an ElectroSpray Ionisation (ESI) ion source. 
 
N-(2-Bromobenzyl)-2-nitrobenzenesulfonamide (8). A solution of 2-nitrobenzene sulfonyl 
chloride (25.00 g, 112.3 mmol) in dichloromethane (100 cm3) was added dropwise to a stirred 
solution of 2-bromobenzylamine hydrochloride (25.00 g, 112.3 mmol) and triethylamine (50.1 
cm3, 36.40 g, 360.0 mmol) in dichloromethane (150 cm3) at 0 °C.  The resulting solution was 
allowed to warm to room temperature and stirred for 16 hours, washed with water (3 x 200 cm3), 
dried (MgSO4), filtered and organic solvent removed under reduced pressure.  The crude product 
was purified by recrystallisation (ethyl acetate/ hexane) to give N-(2-bromobenzyl)-2-
nitrobenzenesulfonamide (8) as a white crystalline solid (36.63 g, 89%); m.p. 101-103 °C; Rf (3: 
2, hexane: ethyl acetate) 0.57; (Found MH+, 370.9694/ 372.9696, C13H12BrN2O4S requires 
370.9701/ 372.9681); νmax /cm-1 3347.8 (NH), 1531.1 (Ar-NO2), 1162.6 (NSO2Ar); δH(300 
MHz; CDCl3) 4.34 (2H, d, J 6.3, CH2), 6.04 (1H, t, J 6.3, NH), 7.00 (1H, td, J 7.8 & 1.6, C-4H), 
7.13 (1H, td, J 7.8 &1.6, C-5H), 7.29 (1H, dd, J 7.8 & 1.6, C-6H), 7.31 (1H, dd, J 7.8 & 1.6, C-
3H), 7.51 (1H, td, J 7.6 & 1.6, C-5’H), 7.58 (1H, td, J 7.6 & 1.6, C-4’H), 7.34 (1H, dd, J 7.6 & 
1.6, C-6’H), 7.83 (1H, dd, J 7.6 & 1.6, C-3’H); δC(75 MHz; CDCl3) 48.20 (CH2), 123.60 (C-2), 
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125.40 (Ar-C-H), 127.63 (Ar-C-H), 129.80 (Ar-C-H), 130.72 (Ar-C-H), 130.92 (Ar-C-H), 
132.80 (Ar-C-H), 132.91 (Ar-C-H), 133.61 (Ar-C-H), 133.86 (quaternary C), 134.93 
(quaternary C), 147.48 (C-2’). 
N-(2-Bromobenzyl)-2-nitro-N-pent-4-ynylbenzenesulfonamide (9). Diethyl azodicarboxylate 
(11.20 cm3, 12.38 g, 71.1 mmol) was added dropwise to a solution of N-(2-bromobenzyl)-2-
nitrobenzenesulfonamide (8) (20.30 g, 54.7 mmol), 4-pentyn-1-ol (6.1 cm3, 5.52 g, 65.6 mmol) 
and triphenylphosphine (18.64 g, 71.1 mmol) in THF (150 cm3) at 0 °C.  The reaction was 
allowed to warm to room temperature and stirred overnight.  Organic solvent was removed under 
reduced pressure and the residue taken up in diethyl ether (70 cm3).  The volume of the solution 
was reduced and the solution filtered to remove triphenylphosphine oxide.  The filtrate was 
reduced in volume and the yellow oil purified by flash column chromatography (3: 2, hexane: 
ethyl acetate) to give the title compound (9) as a light yellow oil (22.96 g, 96%); Rf (3: 2, 
hexane: ethyl acetate) 0.55; (Found MH+, 437.0156/ 439.0169, C18H18BrN2O4S requires 
437.0171/ 439.0150); νmax /cm-1 3300.4 (CCH), 3061.0, 2942.5 (Ar-H), 1544.7 (Ar-NO2), 1371.4 
(NSO2Ar), 1163.8 (NSO2Ar); δH(300 MHz; CDCl3) 1.61 (2H, m, NCH2CH2), 1.87 (1H, t, J 2.6, 
CCH), 2.04 (2H, td, J 7.0 & 2.6, CH2CH2CCH), 3.39 (2H, t, J 7.6, NCH2CH2), 4.66 (2H, s, 
NCH2Ar), 7.09 (1H, td, J 7.6 & 1.6, C-4H), 7.23 (1H, td, J 7.6 & 1.6, C-5H), 7.42 (1H, dd, J 7.6 
& 1.6, C-6H), 7.47 (1H, dd, J 7.6 & 1.6, C-3H), 7.60-7.70 (3H, m, Ar-H), 7.96 (1H, m, Ar-H); 
δC(75 MHz; CDCl3) 15.73 (CH2), 26.78 (CH2), 47.28 (NCH2CH2), 51.48 (NCH2Ar), 69.44 
(CCH), 82.69 (CCH), 123.32 (C-2), 124.33 (Ar-C-H), 127.91 (Ar-C-H), 129.47 (Ar-C-H), 
129.80 (Ar-C-H), 130.86 (Ar-C-H), 132.04 (Ar-C-H), 132.96 (Ar-C-H), 133.09 (C-1), 133.96 
(Ar-C-H), 135.02 (C-1’), 147.88 (C-2’). 
N-(2-Bromobenzyl)pent-4-ynylamine (10). Thiophenol (5.9 cm3, 6.36 g, 57.8 mmol) was 
added to a stirred solution of sulfonamide (9) (22.95 g, 52.5 mmol) and potassium carbonate 
(23.58 g, 170.6 mmol) in acetonitrile (150 cm3) at room temperature.  The resulting solution was 
left to stir overnight at room temperature.  Organic solvent was removed under reduced pressure 
and the residue was taken up in diethyl ether (200 cm3).  Hydrochloric acid (2.0 M solution) was 
added until the solution remained acidic and the resulting solution stirred for ten minutes.  The 
organic layer was separated and washed with dilute hydrochloric acid (100 cm3 of a 1.0 M 
solution).  The combined aqueous phases were washed with diethyl ether (200 cm3) and made 
basic by the addition of solid potassium carbonate.  The aqueous solution was extracted with 
diethyl ether (4 x 150 cm3) and the combined extracts washed with brine (200 cm3), dried 
(MgSO4), filtered and evaporated to dryness under reduced pressure to give the title compound 
(10) as a pale yellow oil (9.94 g, 75%); Rf (3: 2, hexane: ethyl acetate) 0.21; (Found MH+, 
252.0377/ 254.0381, C12H15BrN requires 252.0388/ 254.0367); νmax/ cm-1 3422.5 (NH), 3301.6 
(CCH); δH(300 MHz; CDCl3) 1.39 (1H, br s, NH), 1.64 (2H, quin, J 7.0, NHCH2CH2), 1.86 (1H, 
t, J 2.6, CCH), 2.19 (2H, td, J 7.0 & 2.6, CH2CCH), 2.64 (2H, t, J 7.0, NCH2CH2), 3.76 (2H, s, 
NCH2Ar), 7.01 (1H, td, J 7.5 & 1.0, C-4H), 7.17 (1H, td, J 7.5 & 1.0, C-5H), 7.29 (1H, dd, J 7.5 
& 1.0, C-6H), 7.43 (1H, dd, J 7.5 & 1.0, C-3H); δC(75 MHz; CDCl3) 16.61 (CH2), 28.75 (CH2), 
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47.92 (NCH2CH2), 53.65 (NCH2Ar), 68.61 (CCH), 84.08 (CCH), 123.94 (C-2), 127.39 (C-5), 
128.52 (C-4), 130.19 (C-6), 132.75 (C-3), 139.34 (C-1). 
N-(2-Bromobenzyl)-2-(2-cyano-1-methyl-1H-indol-3-yl)-N-pent-4-ynylacetamide (6). A 
solution of acid chloride (11) (3.25 g, 14.0 mmol) in dichloromethane (50 cm3) was added 
dropwise via cannula to a stirred solution of (2-bromobenzyl)-pent-4-ynylamine (10) (4.58 g, 
18.15 mmol) and N, N-diisopropylethylamine (8.5 cm3, 6.31 g, 48.9 mmol) in dichloromethane 
(100 cm3) at 0 °C under nitrogen.  The resulting mixture was left to stir at 0 °C for one hour, 
allowed to warm to room temperature and then left to stir overnight.  Organic solvent was 
removed under reduced pressure and the residue taken up in dichloromethane (200 cm3), washed 
with HCl (200 cm3 of a 0.5 M solution), saturated sodium hydrogen carbonate (200 cm3) and 
brine (200 cm3).  The organic phase was dried (MgSO4), filtered and solvent removed under 
reduced pressure to give a light green solid which was purified by flash column chromatography 
(2: 1, hexane: ethyl acetate) to give the tertiary amide (6) as a light yellow solid and as a 1: 1.3 
ratio of amide rotamers (5.40 g, 86%); m.p. 119-120 °C; Rf (2: 1, hexane: ethyl acetate) 0.83; 
(Found M+, 447.0956/ 449.0916, C24H22BrN3O requires 447.0947/ 449.0927); νmax /cm-1 3303.1 
(CCH), 3012.8 (Ar-H), 2217.6 (CN), 1653.9 (CONR2); δH(300 MHz; CDCl3) 1.96 (2H, quin, J 
6.8, C-2’’H2 (major + minor)), 2.08 (0.4H, t, J 2.4, C-5’’H (minor)), 2.17 (0.6H, t, J 2.4, C-5’’H 
(major)), 2.34 (1.2H, td, J 6.8 & 2.4, C-3’’H2 (major)), 2.40 (0.8H, td, J 6.8 & 2.4, C-3’’H2 
(minor)), 3.64 (2H, m, C-1’’H2 (major + minor)), 3.83 (1.8H, s, NCH3 (major)), 3.97 (1.2H, s, 
NCH3 (minor)), 4.02 (1.2H, s, CH2CO (major)), 4.25 (0.8H, s, CH2CO (minor)), 4.82 (1.2H, s, 
NCH2Ar (major)), 4.88 (0.8H, s, NCH2Ar (minor)), 6.92 (0.4H, m, Ar-H (minor)), 7.04-7.42 
(5.6H, m, Ar-H (major + minor)), 7.49 (0.4H, d, J 8.0, Ar-H (minor)), 7.70 (0.6H, m, Ar-H 
(major)), 7.76 (0.6H, d, J 8.0, Ar-H (major)), 7.89 (0.4H, d, J 8.0, Ar-H (minor)); δC(75 MHz; 
CDCl3) 15.86 (CH2), 16.17 (CH2), 26.33 (CH2), 27.36 (CH2), 30.76 (CH2), 31.09 (CH2), 31.41 
(NCH3), 31.62 (NCH3), 46.50 (CH2), 46.78 (CH2), 48.65 (CH2), 52.57 (CH2), 69.12 (C-4’’), 
70.00 (C-4’’), 82.72 (C-5’’), 83.40 (C-5’’), 109.82 (C-3), 110.06 (C-7), 110.14 (C-7), 112.93 
(CN), 113.32 (CN), 120.09 (quaternary C), 120.69 (quaternary C), 121.08 (Ar-C-H), 121.18 
(Ar-C-H), 121.43 (Ar-C-H), 122.60 (quaternary C), 123.50 (quaternary C), 126.07 + 126.22 + 
126.77 + 127.66 + 127.33 + 128.85 + 128.99 + 129.21 + 132.75 + 133.08 (Ar-C-H), 135.33 
(quaternary C), 136.25 (quaternary C), 137.96 (quaternary C), 138.14 (quaternary C), 169.43 
(CO), 169.84 (CO);  m/z 449.09 (18.8%, M+ 81Br), 447.10 (20.6, M+ 79Br), 368.17 (62.9), 183.09 
(59.2), 170.99 (91.8), 170.10 (66.6), 169.09 (100.0), 168.08 (43.3), 91.06 (49.9), 90.05 (56.0).  
Radical cyclisation of N-(2-bromobenzyl)-2-(2-cyano-1-methyl-1H-indol-3-yl)-N-pent-4-
ynylacetamide (6). A solution of tri-n-butyltin hydride (0.75 cm3, 0.81 g, 2.78 mmol) and azo-
bis-isobutyronitrile (AIBN) (0.048 g, 2.78 mmol) in t-butyl-m-xylene (30 cm3) were added 
dropwise via syringe pump (6.37 cm3/ hour) to a solution of the amide (6) (1.039 g, 2.32 mmol) 
in t-butyl-m-xylene (90 cm3) at reflux.  Once addition was complete, heating was continued for 2 
hours.  The reaction was allowed to cool and organic solvent removed under reduced pressure 
and the residue taken up in acetonitrile (50 cm3) and extracted with hexane (4 x 50 cm3).  The 
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acetonitrile was removed under reduced pressure and the residue purified by multiple flash 
column chromatography (3: 1, hexane: ethyl acetate) to give a mixture of three products:  
N-benzyl-2-(2-cyano-1-methyl-1H-indol-3-yl)-N-(pent-4-ynyl)acetamide (12). White solid as 
a 1: 1 mix of amide rotamers (0.38 g, 45%); m.p. 82-84 °C; (Found M+, 369.18510, C24H23N3O 
requires 369.18411); νmax /cm-1 3296.7 (CCH), 3059.2, 3030.5, 2938.7 (Ar-H), 2217.5 (CN), 
1648.6 (CONR2); δH(300 MHz; CDCl3) 1.81 (2H, quin, J 7.0, C-2’’H2), 1.94 (0.5H, t, J 2.5, 
CCH), 2.05 (0.5H, t, J 2.5, CCH), 2.19 (1H, td, J 7.0 & 2.5, C-3’’H2), 2.26 (1H, td, J 7.0 & 2.5, 
C-3’’H2), 3.51 (2H, m, C-1’’H2), 3.72 (1.5H, s, NCH3), 3.85 (1.5H, s, NCH3), 3.96 (1H, s, 
CH2CO), 4.09 (1H, s, CH2CO), 4.65 (1H, s, CONCH2Ar), 4.72 (1H, s, CONCH2Ar), 7.09-7.44 
(8H, m, Ar-H), 7.69 (0.5H, d, J 8.1, Ar-H), 7.77 (0.5H, d, J 8.1, Ar-H); δC(75 MHz; CDCl3) 
15.80 (CH2), 16.14 (CH2), 26.28 (CH2), 27.15 (CH2), 30.77 (CH2), 31.27 (CH2), 31.44 (NCH3), 
31.62 (NCH3), 46.15 (CH2), 46.37 (CH2), 48.72 (CH2), 51.91 (CH2), 69.12 (CCH), 69.94 
(CCH), 82.84 (CCH), 83.54 (CCH), 109.76 (C-3), 110.05 (C-7), 110.15 (C-7), 113.21 (CN), 
113.38 (CN), 120.48 (quaternary C), 120.91 (quaternary C), 121.20 (Ar-C-H), 121.29 (Ar-C-H), 
121.43 (Ar-C-H), 125.93 (Ar-C-H), 126.05 (Ar-C-H), 126.14 (Ar-C-H), 126.20 (Ar-C-H), 
127.43 (Ar-C-H), 127.48 (Ar-C-H), 128.18 (Ar-C-H), 128.35 (quaternary C), 128.60 (Ar-C-H), 
128.82 (Ar-C-H), 136.53 (quaternary C), 137.39 (quaternary C), 138.02 (quaternary C), 138.15 
(quaternary C), 169.27 (CO), 169.71 (CO); m/z 369.19 (43.6%, M+), 321.23 (11.4), 273.13 
(77.2), 169.08 (90.9), 168.08 (56.6), 121.06 (79.9), 91.04 (81.4), 77.04 (37.6).  
1-Benzyl-8-methyl-9-methylene-2-oxo-2,3,8,8a,9,10,11,11a-octahydro-1H-pyrrolo[2,3-d] 
carbazole-8a-carbonitrile (7). Colourless oil (0.14 g, 16%); (Found M+, 369.18666, C24H23N3O 
requires 369.18411); νmax /cm-1 2924.4, 2854.8 (Ar-H), 2218.2 (CN), 1694.1 (CONR2); δH(300 
MHz; CD3OD) 1.32 (1H, m, NCHCH2), 2.16-2.28 (2H, m, NCHCH2 & NCHCH2CH2), 2.39 
(1H, m, NCHCH2CH2), 2.63 (3H, s, NCH3), 2.69 & 2.93 (2H, ABq, CH2CO), 3.13 (1H, dd, J 
5.4, NCH), 4.11 & 4.76 (2H, ABq, J 14.7, CONCH2Ar), 5.49 (1H, d, J 1.3, CCH2), 5.63 (1H, s, 
CCH2), 6.67 (1H, d, J 7.5, C-7H), 6.76 (1H, td, J 7.5 & 1.0, C-6H), 6.94 (1H, d, J 7.4, C-4H), 
7.16 (1H, td, J 7.5 & 1.0, C-5H), 7.20 (5H, m, Ar-H); δC(75 MHz; CD3OD) 25.53 (CH2), 29.38 
(CH2), 30.69 (NCH3), 38.38 (CH2), 45.77 (CH2), 53.84 (quaternary C), 65.02 (NCH), 78.91 
(quaternary C), 110.57 (C-7), 116.90 (CN), 119.43 (CCH2), 121.58 (Ar-C-H), 122.59 (Ar-C-H), 
128.87 (Ar-C-H), 129.62 (2 x Ar-C-H), 129.69 (2 x Ar-C-H), 130.55 (Ar-C-H), 134.66 
(quaternary C), 137.19 (quaternary C), 140.86 (quaternary C), 149.83 (quaternary C), 173.36 
(CO); m/z 369.19 (100.0%, M+), 360.95 (16.4), 266.99 (24.4), 169.08 (35.8), 149.02 (32.9), 
91.06 (86.6), 83.09 (35.2).  
12-Benzyl-3-methylene-11-oxo-1,2,3,3a,4,5,10,11,12,12a-decahydropyrrolo[2,3-n] 
phenanthridine-3a-carbonitrile (13). White solid (0.13 g, 15%); m.p. 195-197 °C; (Found M+, 
369.18407, C24H23N3O requires 369.18411); δH(300 MHz; CDCl3) 1.71-1.62 (1H, m, NCHCH2), 
1.97-1.85 (1H, m, NCHCH2), 2.35 (2H, m, NCHCH2CH2), 2.84 & 2.98 (2H, ABq, J 17.5, 
CH2CO), 3.37 (1H, dd, J 12.6 & 3.3, NCH2), 3.52 (1H, d, J 12.6, NCH2), 3.54 (1H, t, J 5.3, 
NCH), 4.04 (1H, d, J 14.9, CONCH2Ar), 4.19 (1H, br s, NH), 4.96 (1H, d, J 14.9, CONCH2Ar), 
5.31 (1H, s, CCH2), 5.62 (1H, s, CCH2), 6.54 (1H, d, J 7.5, C-7H), 6.69 (1H, td, J 7.5 & 1.0, C-
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5H), 7.01-7.07 (2H, m, Ar-H), 7.13-7.24 (5H, m, Ar-H); δC(75 MHz; CDCl3) 24.57 (CH2), 25.38 
(CH2), 42.91 (CH2), 43.01 (quaternary C), 44.70 (CH2), 45.65 (quaternary C), 48.91 (CH2), 
62.13 (NCH), 115.54 (C-7), 116.99 (CCH2), 119.20 (Ar-C-H), 120.12 (quaternary C), 125.53 
(quaternary C), 126.58 (Ar-C-H), 127.75 (Ar-C-H), 128.35 (2 x Ar-C-H), 128.55 (Ar-C-H), 
128.62 (2 x Ar-C-H), 135.67 (quaternary C), 140.27 (quaternary C), 140.87 (quaternary C), 
172.60 (CO); m/z 369.18 (48.0%, M+), 303.15 (21.7), 266.99 (27.8), 245.11 (29.2), 169.08 
(53.2), 91.06 (28.8). 
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